These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme. den Otter JJ; van Schayck CP; Folgering HT; van den Boom G; Akkermans RP; van Weel C Eur J Gen Pract; 2007; 13(2):89-91. PubMed ID: 17534745 [TBL] [Abstract][Full Text] [Related]
4. Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Masoli M; Weatherall M; Holt S; Beasley R Thorax; 2005 Sep; 60(9):730-4. PubMed ID: 16135679 [TBL] [Abstract][Full Text] [Related]
6. Ethics of placebo controlled studies of inhaled steroids for COPD. Hahn DL Thorax; 2004 Jun; 59(6):539; author reply 539-40. PubMed ID: 15170046 [No Abstract] [Full Text] [Related]
7. Do inhaled corticosteroids slow FEV1 decline in COPD after all? Duerden MG Thorax; 2004 Jun; 59(6):538-9; author reply 539-40. PubMed ID: 15170045 [No Abstract] [Full Text] [Related]
8. Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study. van der Valk P; Monninkhof E; van der Palen J; Zielhuis G; van Herwaarden C Am J Respir Crit Care Med; 2002 Nov; 166(10):1358-63. PubMed ID: 12406823 [TBL] [Abstract][Full Text] [Related]
9. New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine. van Overveld FJ; Demkow U; Górecka D; de Backer WA; Zielinski J J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():135-42. PubMed ID: 16204787 [TBL] [Abstract][Full Text] [Related]
10. Inhaled corticosteroids and COPD. Farquhar D CMAJ; 2000 Aug; 163(3):326-7. PubMed ID: 10951737 [No Abstract] [Full Text] [Related]
11. Inhaled corticosteroids are beneficial in chronic obstructive pulmonary disease. Calverley PM Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):341-2; discussion 344. PubMed ID: 10673165 [No Abstract] [Full Text] [Related]
12. Clinical effects of inhaled corticosteroids in chronic obstructive pulmonary disease. Jones PW Proc Am Thorac Soc; 2004; 1(3):167-70. PubMed ID: 16113430 [TBL] [Abstract][Full Text] [Related]
13. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding. Tashkin DP Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901 [TBL] [Abstract][Full Text] [Related]
14. Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD. Kim WJ; Sheen SS; Kim TH; Huh JW; Lee JH; Kim EK; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Oh YM; Lee SD Respirology; 2009 Mar; 14(2):260-3. PubMed ID: 19210659 [TBL] [Abstract][Full Text] [Related]
18. [Inhalation of beta-2 agonists or corticosteroids as single drugs in comparison with combination therapy of patients with COPD]. Steurer-Stey C Praxis (Bern 1994); 2003 Jul; 92(31-32):1324-5. PubMed ID: 12934343 [No Abstract] [Full Text] [Related]
19. Inhaled steroids for chronic obstructive pulmonary disease--where are we now? Taylor DR; Wong CS N Z Med J; 2000 Aug; 113(1115):337-8. PubMed ID: 11008612 [No Abstract] [Full Text] [Related]